Principal Scientist, Biotransformation of Next Gen Biologics and Targeted Therapies – Merck Sharp & Dohme – San Francisco, CA

The ADME, Discovery Bioanalytical and Discovery Toxicology (ADMET/BA) function within Preclinical development (PCD) of our Research & Development Division South…...

Click to view original post